Tag Archives: RELOPDUO
BMS launches dual immunotherapy for metastatic melanoma
Bristol Myers Squibb (BMS) has announced the launch of RELOPDUO, a fixed-dose combination of nivolumab [...]
28
Jul
Jul
Bristol Myers Squibb (BMS) has announced the launch of RELOPDUO, a fixed-dose combination of nivolumab [...]